JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHEN, K. K.
Right arrow Articles by CHEN, A. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CHEN, K. K.
Right arrow Articles by CHEN, A. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 51, Issue 1, 23-34, 1934
Copyright © 1934 by American Society for Pharmacology and Experimental Therapeutics


THE ACTION OF CRYSTALLINE THEVETIN, A CARDIAC GLUCOSIDE OF THEVETIA NERIIFOLIA

K. K. CHEN 1 and A. LING CHEN 1

1 From the Lilly Research Laboratories, Indianapolis, Indiana

Thevetin, a glucoside of be-still nuts (Thevetia neriifolia), has a digitalis-like action on amphibian and mammalian hearts. Its minimal systolic dose in frogs lies between 0.004 and 0.005 mgm. per gram, and its cat unit is 0.85 mgm. per kilogram. Thevetin is thus one-eighth to one-seventh as toxic but also one-eighth to one-seventh as potent as ouabain (G-strophanthin), weight for weight. Like other digitalis bodies, it causes nausea and vomiting in sublethal doses, raises the blood pressure, and stimulates isolated smooth muscle organs. Its action is less persistent than that of digitalis.

The kernels of be-still nuts contain approximately 3.6 to 4 per cent of thevetin as shown by physiological assaying.

Submitted on January 27, 1934







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1934 by the American Society for Pharmacology and Experimental Therapeutics.